Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease. (Q40094359)
Jump to navigation
Jump to search
scientific article published on 9 January 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease. |
scientific article published on 9 January 2016 |
Statements
Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease (English)
1 reference
Hannele Yki-Järvinen
Johanna Arola
Marja Leivonen